2.7.4.14	5'-nucleotidase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3036196&form=6&db=m	Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.	causal interaction,unassigned	3,0	
2.7.4.14	Abortion, Missed	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32323732&form=6&db=m	Pigment epithelium?derived factor facilitates NLRP3 inflammasome activation through downregulating cytidine monophosphate kinase 2: A potential treatment strategy for missed abortion.	causal interaction,therapeutic application,unassigned	1,4,0	
2.7.4.14	Acquired Immunodeficiency Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15163660&form=6&db=m	Substrate-induced conformational changes in human UMP/CMP kinase.	ongoing research,unassigned	4,0	
2.7.4.14	Acute Lung Injury	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34037470&form=6&db=m	MiR-494-3p alleviates acute lung injury through regulating NLRP3 activation by targeting CMPK2.	unassigned	-	
2.7.4.14	Atherosclerosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33874983&form=6&db=m	Mitochondrial protein CMPK2 regulates IFN alpha-enhanced foam cell formation, potentially contributing to premature atherosclerosis in SLE.	causal interaction,diagnostic usage,ongoing research,unassigned	2,3,2,0	
2.7.4.14	Bacterial Infections	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33186560&form=6&db=m	CMPK2 of triploid crucian carp is involved in immune defense against bacterial infection.	unassigned	-	
2.7.4.14	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27558661&form=6&db=m	Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.	diagnostic usage,unassigned	4,0	
2.7.4.14	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34438242&form=6&db=m	Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11).	ongoing research,therapeutic application,unassigned	2,4,0	
2.7.4.14	Carcinoma, Hepatocellular	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=179702&form=6&db=m	Differences between pyrimidine nucleoside monophosphate kinase from rat Novikoff ascites hepatoma and rat liver.	ongoing research,unassigned	3,0	
2.7.4.14	Carcinoma, Hepatocellular	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=211381&form=6&db=m	Pyrimidine nucleoside monophosphate kinase from rat liver and rat Novikoff ascites hepatoma (EC 2.7.4.14).	ongoing research,unassigned	1,0